We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 35,319

Recent Patent Office decision provides further clarity in patentability of nucleic acids in Australia
  • Fisher Adams Kelly Callinans
  • Australia
  • December 9 2016

As has been widely reported, including in our previous articles such as this, the patentability or otherwise of isolated nucleic acids has been a


Australia & New Zealand to share single regime for Patent Attorney qualification and code of conduct after passage of Patents Amendment Bill
  • Fisher Adams Kelly Callinans
  • Australia, New Zealand
  • December 9 2016

Since 1996 it has been the case that Patent attorneys first registered in either Australia or New Zealand have been allowed to register separately to


Patent Litigation in China
  • CCPIT Patent & Trademark Law Office
  • China
  • December 9 2016

The Chinese legal system provides patent protection for inventions.There are three types of patents under Patent Law, namely a patent for an


How will Brexit affect Supplementary Protection Certificates (SPCs)?
  • Marks & Clerk
  • European Union, United Kingdom
  • December 9 2016

SPCs are an important additional form of protection, particularly for the pharmaceutical industry, by which the normal maximum 20 year term of


Court Sua Sponte Dismisses Patent Case for Improper Venue
  • Holland & Knight LLP
  • USA
  • December 9 2016

Judge Shadur sua sponte dismissed plaintiff Anuwave’s patent complaint for improper venue with leave


A comparative study of strategies for patenting human therapeutics in the Asia Pacific Region: IP In Depth
  • Fisher Adams Kelly Callinans
  • Asia-Pacific, Australia
  • December 9 2016

In the last century, innovations in the life sciences have allowed for treatment and prevention of numerous diseases and disorders, enabling higher


Supreme Court Takes Small Bite of Apple, Leaves Bigger Questions Aside on Design Patent Damages
  • Bradley Arant Boult Cummings LLP
  • USA
  • December 8 2016

A unanimous Supreme Court held in Samsung Electronics Co. v. Apple Inc. that Section 289 of the Patent Act does not demand that the entire, infringing


Enablement and examination post raising the bar
  • FPA Patent Attorneys
  • Australia
  • December 8 2016

The amendments to the Patents Act under Raising the Bar brought changes to the enablement provisions required by Australian patent specifications


Cuozzo and Inter Partes Review: Are Patents Getting Easier to Invalidate?
  • Workman Nydegger
  • USA
  • December 8 2016

Recently, the Supreme Court decided the issue of whether the decision of the USPTO to institute an inter partes review (IPR) of claims from which a


Scotus: Damages for Design Patents can be based on parts
  • Valea AB
  • USA
  • December 7 2016

The Supreme Court of the United States (SCOTUS), by unanimous decision, reversed yesterday a damages award against Samsung of approximately $400, in